General Accident Insurance Company Jamaica Limited (JMSE:GENAC)

Ligand Pharmaceuticals Revenue

General Accident Insurance Company Jamaica had revenue of 3.17B JMD in the quarter ending March 31, 2025, with 20.15% growth. This brings the company's revenue in the last twelve months to 12.24B, up 33.74% year-over-year. In the year 2024, General Accident Insurance Company Jamaica had annual revenue of 11.71B with 33.13% growth.

• Revenue (ttm): 12.24B
• Revenue Growth: +33.74%
• P/S Ratio: 0.43
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 5.31B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	11.71B	2.91B	33.13%
Dec 31, 2023	8.80B	1.74B	24.72%
Dec 31, 2022	7.05B	2.89B	69.45%
Dec 31, 2021	4.16B	371.26M	9.79%
Dec 31, 2020	3.79B	482.89M	14.60%